{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "42023-173",
      "generic_name": "Ganciclovir",
      "labeler_name": "Par Health USA, LLC",
      "brand_name": "Ganciclovir",
      "active_ingredients": [
        {
          "name": "GANCICLOVIR SODIUM",
          "strength": "500 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "42023-173-25",
          "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (42023-173-25)  / 10 mL in 1 VIAL, SINGLE-DOSE (42023-173-01)",
          "marketing_start_date": "20161206",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "393ba8cf-2ed2-408b-b60e-27a9262631ab",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20161206",
      "product_id": "42023-173_393ba8cf-2ed2-408b-b60e-27a9262631ab",
      "application_number": "ANDA204950",
      "brand_name_base": "Ganciclovir",
      "pharm_class": [
        "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
        "DNA Polymerase Inhibitors [MoA]",
        "Nucleoside Analog Antiviral [EPC]",
        "Nucleoside Analog [EXT]"
      ]
    }
  ]
}